IDEXX Laboratories Inc. planned insider sales
In the last twelve months insiders at IDEXX Laboratories Inc. filed 12 Form 144 notices of planned sales, 88,029 shares worth $58.7 million at the time of filing, from 10 sellers. The latest, filed 4 November 2026: Junius Daniel M (director), 500 shares worth $345,835, planned for around 4 November 2026 through Fidelity Brokerage Services LLC.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 4 November 2026 | Junius Daniel M | Director | 500 | $345,835 | 4 November 2026 | 1,200 shares from 4 November 2026 | Fidelity Brokerage Services LLC | Open Market Purchase | Form 144 |
| 4 November 2026 | Michael J Lane | Officer | 3,979 | $2.7 million | 4 November 2026 | 3,979 shares from 4 November 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Employee Stock Purchase Plan; Exercised Shares; Restricted Stock | Form 144 |
| 4 November 2026 | Sharon E Underberg | Officer | 8,906 | $6.1 million | 4 November 2026 | 8,906 shares from 4 November 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 4 November 2026 | Jonathan J Mazelsky | Officer, Director | 25,140 | $17.7 million | 4 November 2026 | 25,140 shares from 4 November 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 4 September 2026 | Lawrence D Kingsley | Director | 2,203 | $1.2 million | 4 September 2026 | 2,203 shares from 4 September 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 20 May 2026 | Margaret Anne Szostak | Director | 1,344 | $744,012 | 20 May 2026 | No matching Form 4 sale | Goldman Sachs & Co. LLC | Restricted Stock Units | Form 144 |
| 3 March 2026 | Nimrata K Hunt | Officer | 1,758 | $1.1 million | 3 March 2026 | 1,758 shares from 3 March 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercised Shares | Form 144 |
| 26 February 2026 | Jonathan J Mazelsky | Officer, Director | 23,326 | $15.3 million | 26 February 2026 | 23,326 shares from 26 February 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 25 February 2026 | Nimrata K Hunt | Officer | 2,693 | $1.8 million | 25 February 2026 | 2,693 shares from 26 February 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercised Shares | Form 144 |
| 17 February 2026 | Sophie V Vandebroek | Director | 1,464 | $920,293 | 17 February 2026 | 1,464 shares from 17 February 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock; Stock Option Exercise | Form 144 |
| 17 February 2026 | Michael G Erickson | Officer | 5,371 | $3.4 million | 17 February 2026 | 5,371 shares from 17 February 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 10 February 2026 | George Fennell | Officer | 11,345 | $7.3 million | 10 February 2026 | 11,345 shares from 10 February 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.